This site is intended for healthcare professionals only
LoginRegister
NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, CefiximeNPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime
Rajasthan Medical Services Corp Bans 7 Pharma Firms, 40 Drugs Over Quality ConcernsHealth Ministry Drafts Rule Change to Halve Drug Trial Approval Time from 90 to 45 Days
Karnataka AYUSH Dept Under Fire: MLA Alleges Corrupt Procurement, Expired Drugs Sent to Mangaluru HospitalTelegram Trading Scam Tricks Kochi Pharma Firm Owner Into Losing Rs 25 Crore
India targets new markets for pharma export growth amid US tariffs concernsIndia targets new markets for pharma export growth amid US tariffs concerns
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Biopharma Gets CDSCO Panel Nod for Phase IV Trial of Denosumab Injection in Cancer Patients
Tamil Nadu to Mandate National Formulary Subscription for All Newly Registered Pharmacists127 Cancer Drugs Under Scanner as Delhi Govt Orders Fresh Testing of 75 Cleared Samples
India emerges as global hub of Global Capability Centers for life sciencesIndia emerges as global hub of Global Capability Centers for life sciences: Report
Delhi HC Orders Fresh Inspection of Palamur Biosciences After PETA AllegationsPETA Slams Hyderabad Pharma Lab, Seeks CCSEA Action to Rescue 1,200 Beagles, Monkeys
Novartis concludes acquisition of Tourmaline BioNovartis Leqvio shows statistically significant, clinically meaningful early LDL-C goal achievement...
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreRoyalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million
Maharashtra Adds 38 New Pharmacy Colleges, Over 6000 Students Get B.Pharm Seats in Third CAP RoundPCI Crackdown: No Admissions at 128 D.Pharm, 48 B.Pharm Colleges in Maharashtra for 2025-26
Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in ChinaBoehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant...
X